108 related articles for article (PubMed ID: 20345477)
1. First-line therapy with doxycycline in ocular adnexal mucosa-associated lymphoid tissue lymphoma: a retrospective analysis of clinical predictors.
Kim TM; Kim KH; Lee MJ; Jeon YK; Lee SH; Kim DW; Kim CW; Kim IH; Khwarg SI; Heo DS
Cancer Sci; 2010 May; 101(5):1199-203. PubMed ID: 20345477
[TBL] [Abstract][Full Text] [Related]
2. Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: a multicenter prospective trial.
Ferreri AJ; Ponzoni M; Guidoboni M; Resti AG; Politi LS; Cortelazzo S; Demeter J; Zallio F; Palmas A; Muti G; Dognini GP; Pasini E; Lettini AA; Sacchetti F; De Conciliis C; Doglioni C; Dolcetti R
J Natl Cancer Inst; 2006 Oct; 98(19):1375-82. PubMed ID: 17018784
[TBL] [Abstract][Full Text] [Related]
3. Chlamydophila psittaci eradication with doxycycline as first-line targeted therapy for ocular adnexae lymphoma: final results of an international phase II trial.
Ferreri AJ; Govi S; Pasini E; Mappa S; Bertoni F; Zaja F; Montalbán C; Stelitano C; Cabrera ME; Giordano Resti A; Politi LS; Doglioni C; Cavalli F; Zucca E; Ponzoni M; Dolcetti R
J Clin Oncol; 2012 Aug; 30(24):2988-94. PubMed ID: 22802315
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of tumor-infiltrating FOXP3+ T cells in patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma.
Kim KH; Kim TM; Go H; Kim WY; Jeon YK; Lee SH; Kim DW; Khwarg SI; Kim CW; Heo DS
Cancer Sci; 2011 Nov; 102(11):1972-6. PubMed ID: 21812857
[TBL] [Abstract][Full Text] [Related]
5. Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy.
Ferreri AJ; Ponzoni M; Guidoboni M; De Conciliis C; Resti AG; Mazzi B; Lettini AA; Demeter J; Dell'Oro S; Doglioni C; Villa E; Boiocchi M; Dolcetti R
J Clin Oncol; 2005 Aug; 23(22):5067-73. PubMed ID: 15968003
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes of first-line treatment with doxycycline in patients with previously untreated ocular adnexal marginal zone B cell lymphoma.
Han JJ; Kim TM; Jeon YK; Kim MK; Khwarg SI; Kim CW; Kim IH; Heo DS
Ann Hematol; 2015 Apr; 94(4):575-81. PubMed ID: 25338969
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: a multiinstitutional, retrospective review of 50 patients.
Uno T; Isobe K; Shikama N; Nishikawa A; Oguchi M; Ueno N; Itami J; Ohnishi H; Mikata A; Ito H
Cancer; 2003 Aug; 98(4):865-71. PubMed ID: 12910532
[TBL] [Abstract][Full Text] [Related]
8. Meta-analyses of the association between Chlamydia psittaci and ocular adnexal lymphoma and the response of ocular adnexal lymphoma to antibiotics.
Husain A; Roberts D; Pro B; McLaughlin P; Esmaeli B
Cancer; 2007 Aug; 110(4):809-15. PubMed ID: 17594698
[TBL] [Abstract][Full Text] [Related]
9. Outcome and prognostic factors in ocular adnexal lymphoma.
Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
[TBL] [Abstract][Full Text] [Related]
10. Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis.
Ang MK; Hee SW; Quek R; Yap SP; Loong S; Tan L; Tao M; Lim ST
Ann Hematol; 2009 May; 88(5):417-24. PubMed ID: 18777110
[TBL] [Abstract][Full Text] [Related]
11. Periocular mucosa-associated lymphoid/low grade lymphomas: treatment with antibiotics.
Abramson DH; Rollins I; Coleman M
Am J Ophthalmol; 2005 Oct; 140(4):729-30. PubMed ID: 16226528
[TBL] [Abstract][Full Text] [Related]
12. Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome.
Levy M; Copie-Bergman C; Traulle C; Lavergne-Slove A; Brousse N; Flejou JF; de Mascarel A; Hemery F; Gaulard P; Delchier JC;
Am J Gastroenterol; 2002 Feb; 97(2):292-7. PubMed ID: 11866264
[TBL] [Abstract][Full Text] [Related]
13. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
Chen LT; Lin JT; Tai JJ; Chen GH; Yeh HZ; Yang SS; Wang HP; Kuo SH; Sheu BS; Jan CM; Wang WM; Wang TE; Wu CW; Chen CL; Su IJ; Whang-Peng J; Cheng AL
J Natl Cancer Inst; 2005 Sep; 97(18):1345-53. PubMed ID: 16174856
[TBL] [Abstract][Full Text] [Related]
14. Extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue-type of the orbit and ocular adnexa.
Lee JL; Kim MK; Lee KH; Hyun MS; Chung HS; Kim DS; Shin SO; Cho HS; Bae SH; Ryoo HM
Ann Hematol; 2005 Jan; 84(1):13-8. PubMed ID: 15309523
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of the TNM-based staging system of ocular adnexal extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma).
Lee SE; Paik JS; Cho WK; Choi BO; Lee SN; Jung SE; Park KS; Kang CS; Kim SH; Yang SW; Cho SG
Am J Hematol; 2011 Mar; 86(3):262-6. PubMed ID: 21328439
[TBL] [Abstract][Full Text] [Related]
16. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up.
Montalban C; Santon A; Boixeda D; Redondo C; Alvarez I; Calleja JL; de Argila CM; Bellas C
Haematologica; 2001 Jun; 86(6):609-17. PubMed ID: 11418369
[TBL] [Abstract][Full Text] [Related]
17. Low absolute lymphocyte count is a poor prognostic marker in patients with diffuse large B-cell lymphoma and suggests patients' survival benefit from rituximab.
Oki Y; Yamamoto K; Kato H; Kuwatsuka Y; Taji H; Kagami Y; Morishima Y
Eur J Haematol; 2008 Dec; 81(6):448-53. PubMed ID: 18691256
[TBL] [Abstract][Full Text] [Related]
18. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome.
Tsang RW; Gospodarowicz MK; Pintilie M; Wells W; Hodgson DC; Sun A; Crump M; Patterson BJ
J Clin Oncol; 2003 Nov; 21(22):4157-64. PubMed ID: 14615444
[TBL] [Abstract][Full Text] [Related]
19. Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment.
Nakamura S; Matsumoto T; Suekane H; Nakamura S; Matsumoto H; Esaki M; Yao T; Iida M
Cancer; 2005 Aug; 104(3):532-40. PubMed ID: 15937928
[TBL] [Abstract][Full Text] [Related]
20. Rituximab in patients with mucosal-associated lymphoid tissue-type lymphoma of the ocular adnexa.
Ferreri AJ; Ponzoni M; Martinelli G; Muti G; Guidoboni M; Dolcetti R; Doglioni C
Haematologica; 2005 Nov; 90(11):1578-9. PubMed ID: 16266908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
